Journal article
What Predicts Early Fracture or Bone Loss on Bisphosphonate Therapy?
Abstract
Factors predicting early fracture or bone loss on bisphosphonate therapy are not well defined. We studied 1588 patients over the age of 50 yr who were started on cyclic etidronate (1119) or alendronate (469) in the CANDOO (Canadian Database for Osteoporosis and Osteopenia Patients) Study. Incident fracture within 2 yr of starting therapy occurred in 31 patients and was independently predicted by a previous history of nonvertebral fracture (odds …
Authors
Sawka AM; Adachi JD; Ioannidis G; Olszynski WP; Brown JP; Hanley DA; Murray T; Josse R; Sebaldt RJ; Petrie A
Journal
Journal of Clinical Densitometry, Vol. 6, No. 4, pp. 315–322
Publisher
Elsevier
Publication Date
2003
DOI
10.1385/jcd:6:4:315
ISSN
1094-6950